Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro.

Harel, W

Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro. [electronic resource] - Cancer research Oct 1990 - 6311-5 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0008-5472


Antibodies, Monoclonal--administration & dosage
Antibody Specificity
Antibody-Dependent Cell Cytotoxicity--immunology
Antigens, Neoplasm
Antigens, Surface--immunology
Gangliosides--immunology
Humans
Immunotherapy--methods
Killer Cells, Lymphokine-Activated--immunology
Melanoma--immunology
Melanoma-Specific Antigens
Neoplasm Proteins--immunology
Tumor Cells, Cultured